In another study on the treatment of women with HER-2- negative operative breast cancer with reparixin only, the frequency of cancer stem cells, indicated by aldehyde dehydrogenase, CD44+/CD24- expression, was reduced (113). The gene discussed is ERBB2; the disease is breast cancer.